LBA-03 Efficacy and safety of regorafenib versus placebo in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: results of the international, randomized phase 3 RESORCE trial

Details 詳細情報について

• CRID

  1873961342996915712

• DOI

  10.1093/annonc/mdw237.03

• ISSN

  09237534

• Data Source

  • OpenAIRE